deoxycytidine and Allergy, Drug

deoxycytidine has been researched along with Allergy, Drug in 20 studies

Research

Studies (20)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (5.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (30.00)	29.6817
2010's	13 (65.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ando, Y; Hayashi, T; Ikeda, Y; Ito, K; Kawada, K; Kumazawa, S; Maeda, K; Matsuoka, H; Murai, S; Ohta, H; Shiouchi, H; Yamada, S; Yasuda, K	1
Mahdi, H; Maurer, K; Michener, C; Rose, PG	1
Bayonne Kombo, ES; Gathse, A	1
Amorin, S; Brice, P; Deau, B; Guillermin, Y; Harel, S; Lebras, L; Michallet, AS; Reynes, C; Salles, G; Subtil, F	1
Asami, Y; Iiba, M; Kitagawa, R; Kondo, K; Sato, N; Sugita, M; Tadauchi, K; Tsunoda, H; Uenoyama, A	1
Arenare, L; Bergamini, A; Cecere, SC; Della Pepa, C; Di Napoli, M; Facchini, G; Gargiulo, P; Mangili, G; Pignata, S; Pisano, C; Rossetti, S; Tambaro, R	1
An, X; Feng, F; He, YJ; Li, YH; Wang, FH; Wang, ZQ; Xiang, XJ; Xu, RH; Zhao, Y	1
Burris, HA; Greco, FA; Hainsworth, JD; Inhorn, RC; Lane, CM; Reeves, J; Rubinsak, J; Spigel, DR; Thompson, DS; Vazquez, ER; Webb, C	1
Chakerian, P; Kaley, K; Lamb, L; Saif, MW	1
Pineda de la Losa, F; Prieto García, A	1
Chang, YS; Cho, SH; Kang, SY; Kim, JH; Kim, MH; Kim, MY; Kim, SH; Kim, YJ; Lee, JS; Lee, KW; Lee, SY; Min, KU; Song, WJ; Yang, MS	1
Aguilella-Vizcaíno, MJ; Calleja-Hernández, MÁ; Cortés-Funes Castro, H; Cortijo-Cascajares, S; García-Escobar, I; Herreros-de-Tejada, A; Nacle-López, I	1
Loulergue, P; Mir, O	1
Needle, MN	1
Liu, CY	1
Ardavanis, A; Baziotis, N; Gerasimidis, G; Rigatos, G; Tryfonopoulos, D; Yiotis, I	1
Fung, A; Viale, PH; Zitella, L	1
de Perio, MA; Fichtenbaum, CJ; Frame, PT; Gomez, FJ	1
Foussereau, J; Tomb, RR	1

Reviews

2 review(s) available for deoxycytidine and Allergy, Drug

Article	Year
Safety experience with IMC-C225, an anti-epidermal growth factor receptor antibody. Seminars in oncology, 2002, Volume: 29, Issue:5 Suppl 14 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cetuximab; Cisplatin; Clinical Trials as Topic; Colorectal Neoplasms; Deoxycytidine; Drug Eruptions; Drug Hypersensitivity; Drug Interactions; Gemcitabine; Head and Neck Neoplasms; Humans; Irinotecan; Pancreatic Neoplasms	2002
Advanced colorectal cancer: current treatment and nursing management with economic considerations. Clinical journal of oncology nursing, 2005, Volume: 9, Issue:5 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Camptothecin; Capecitabine; Cause of Death; Colorectal Neoplasms; Deoxycytidine; Diarrhea; Drug Costs; Drug Hypersensitivity; Drug Industry; Female; Fluorouracil; Humans; Irinotecan; Male; Medical Assistance; Nausea; Neoplasm Staging; Nurse's Role; Oncology Nursing; Organoplatinum Compounds; Oxaliplatin; Paresthesia; Patient Education as Topic; Treatment Outcome; United States; Vomiting	2005

Article

Year

Safety experience with IMC-C225, an anti-epidermal growth factor receptor antibody.

Seminars in oncology, 2002, Volume: 29, Issue:5 Suppl 14

Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cetuximab; Cisplatin; Clinical Trials as Topic; Colorectal Neoplasms; Deoxycytidine; Drug Eruptions; Drug Hypersensitivity; Drug Interactions; Gemcitabine; Head and Neck Neoplasms; Humans; Irinotecan; Pancreatic Neoplasms

2002

Advanced colorectal cancer: current treatment and nursing management with economic considerations.

Clinical journal of oncology nursing, 2005, Volume: 9, Issue:5

Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Camptothecin; Capecitabine; Cause of Death; Colorectal Neoplasms; Deoxycytidine; Diarrhea; Drug Costs; Drug Hypersensitivity; Drug Industry; Female; Fluorouracil; Humans; Irinotecan; Male; Medical Assistance; Nausea; Neoplasm Staging; Nurse's Role; Oncology Nursing; Organoplatinum Compounds; Oxaliplatin; Paresthesia; Patient Education as Topic; Treatment Outcome; United States; Vomiting

2005

Trials

1 trial(s) available for deoxycytidine and Allergy, Drug

Article	Year
Phase II study of cetuximab, docetaxel, and gemcitabine in patients with previously untreated advanced non-small-cell lung cancer. Clinical lung cancer, 2010, Volume: 11, Issue:3 Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cetuximab; Deoxycytidine; Disease-Free Survival; Docetaxel; Drug Hypersensitivity; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Taxoids; Tennessee; Treatment Outcome	2010

Article

Year

Phase II study of cetuximab, docetaxel, and gemcitabine in patients with previously untreated advanced non-small-cell lung cancer.

Clinical lung cancer, 2010, Volume: 11, Issue:3

Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cetuximab; Deoxycytidine; Disease-Free Survival; Docetaxel; Drug Hypersensitivity; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Taxoids; Tennessee; Treatment Outcome

2010

Other Studies

17 other study(ies) available for deoxycytidine and Allergy, Drug

Article	Year
Comparison between hypersensitivity reactions to cycles of modified FOLFOX6 and XELOX therapies in patients with colorectal cancer. Cancer chemotherapy and pharmacology, 2017, Volume: 79, Issue:5 Topics: Aged; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colorectal Neoplasms; Combined Modality Therapy; Deoxycytidine; Dexamethasone; Drug Hypersensitivity; Female; Fluorouracil; Humans; Incidence; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates; Retrospective Studies; Risk Factors	2017
Universal tolerance of nab-paclitaxel for gynecologic malignancies in patients with prior taxane hypersensitivity reactions. Journal of gynecologic oncology, 2017, Volume: 28, Issue:4 Topics: Adult; Aged; Albumins; Anemia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Cisplatin; Deoxycytidine; Docetaxel; Drug Hypersensitivity; Female; Gemcitabine; Genital Neoplasms, Female; Humans; Middle Aged; Nervous System Diseases; Neutropenia; Paclitaxel; Retreatment; Retrospective Studies; Taxoids; Thrombocytopenia	2017
[Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV]. Medecine et maladies infectieuses, 2013, Volume: 43, Issue:3 Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Asthenia; Benzoxazines; Cyclopropanes; Deoxycytidine; Dideoxynucleosides; Drug Eruptions; Drug Hypersensitivity; Drug Substitution; Emtricitabine; Female; Fever; HIV Infections; Humans; Lamivudine; Nevirapine; Organophosphonates; Reverse Transcriptase Inhibitors; Syndrome; Tenofovir	2013
Sequential combination of gemcitabine, vinorelbine, pegylated liposomal doxorubicin and brentuximab as a bridge regimen to transplant in relapsed or refractory Hodgkin lymphoma. Haematologica, 2015, Volume: 100, Issue:7 Topics: Adolescent; Adult; Anemia; Antineoplastic Agents; Brentuximab Vedotin; Deoxycytidine; Doxorubicin; Drug Administration Schedule; Drug Hypersensitivity; Female; Gemcitabine; Hodgkin Disease; Humans; Immunoconjugates; Male; Neutropenia; Polyethylene Glycols; Recurrence; Remission Induction; Retrospective Studies; Survival Analysis; Treatment Outcome; Vinblastine; Vinorelbine	2015
[A Patient with Recurrent Ovarian Cancer Who Was Hypersensitive to Carboplatin Exhibited Complete Response to Gemcitabine and Nedaplatin]. Gan to kagaku ryoho. Cancer & chemotherapy, 2015, Volume: 42, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Deoxycytidine; Drug Hypersensitivity; Female; Gemcitabine; Humans; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Ovarian Neoplasms; Recurrence	2015
Cisplatin can be safely administered to ovarian cancer patients with hypersensitivity to carboplatin. Gynecologic oncology, 2017, Volume: 144, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Deoxycytidine; Doxorubicin; Drug Hypersensitivity; Female; Gemcitabine; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Polyethylene Glycols; Retrospective Studies	2017
[Clinical features of hypersensitivity reactions to oxaliplatin among Chinese colorectal cancer patients]. Chinese journal of cancer, 2010, Volume: 29, Issue:1 Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adolescent; Adult; Aged; Anaphylaxis; Anti-Allergic Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asian People; Capecitabine; Child; Colorectal Neoplasms; Deoxycytidine; Drug Hypersensitivity; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates; Retrospective Studies; Sex Factors; Young Adult	2010
First case report associating gemcitabine with hypersensitivity reaction in a patient with pancreatic cancer. JOP : Journal of the pancreas, 2010, May-05, Volume: 11, Issue:3 Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Deoxycytidine; Drug Hypersensitivity; Female; Gemcitabine; Humans; Middle Aged; Pancreatic Neoplasms	2010
Immunoglobulin E-mediated severe anaphylaxis to paclitaxel. Journal of investigational allergology & clinical immunology, 2010, Volume: 20, Issue:2 Topics: Anaphylaxis; Antineoplastic Combined Chemotherapy Protocols; Asthma; Cisplatin; Deoxycytidine; Drug Hypersensitivity; Dyspnea; Epitopes; Female; Gemcitabine; Humans; Hypersensitivity, Immediate; Hypotension; Immunoglobulin E; Middle Aged; Neoplasms; Paclitaxel; Pulmonary Atelectasis; Remission Induction; Skin Tests	2010
Hypersensitivity reactions to oxaliplatin: clinical features and risk factors in Koreans. Asian Pacific journal of cancer prevention : APJCP, 2012, Volume: 13, Issue:4 Topics: Aged; Anaphylaxis; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Dexamethasone; Drug Eruptions; Drug Hypersensitivity; Female; Fluorouracil; Gemcitabine; Glucocorticoids; Histamine H1 Antagonists; Humans; Hydrocortisone; Leucovorin; Male; Middle Aged; Multivariate Analysis; Neoplasms; Organoplatinum Compounds; Oxaliplatin; Prevalence; Republic of Korea; Retrospective Studies; Risk Factors	2012
Effectiveness of oxaliplatin desensitization protocols. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2013, Volume: 15, Issue:3 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Desensitization, Immunologic; Drug Hypersensitivity; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Prognosis; Retrospective Studies; Skin Tests	2013
Letter to the editor: Hypersensitivity to lamivudine and emtricitabine. Current HIV research, 2012, Volume: 10, Issue:7 Topics: Aged; Anti-HIV Agents; Deoxycytidine; Dose-Response Relationship, Drug; Drug Hypersensitivity; Drug Therapy, Combination; Emtricitabine; Female; HIV Seropositivity; HIV-1; Humans; Lamivudine	2012
Fluorouracil for allergic reactions to capecitabine. The Annals of pharmacotherapy, 2002, Volume: 36, Issue:12 Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Capecitabine; Deoxycytidine; Drug Hypersensitivity; Female; Fluorouracil; Humans; Salvage Therapy	2002
Non-allergic nature of docetaxel-induced acute hypersensitivity reactions. Anti-cancer drugs, 2004, Volume: 15, Issue:6 Topics: Administration, Oral; Adult; Blood Pressure; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Deoxycytidine; Docetaxel; Doxorubicin; Drug Hypersensitivity; Female; Gemcitabine; Histamine; Histamine Antagonists; Humans; Hypersensitivity, Immediate; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Paclitaxel; Premedication; Serine Endopeptidases; Tachycardia; Taxoids; Time Factors; Tryptases	2004
Two-once-daily fixed-dose NRTI combinations for HIV. The Medical letter on drugs and therapeutics, 2005, Feb-28, Volume: 47, Issue:1203 Topics: Anti-HIV Agents; Deoxycytidine; Dideoxynucleosides; Dose-Response Relationship, Drug; Drug Combinations; Drug Hypersensitivity; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; HIV Infections; Humans; Lamivudine; Organophosphorus Compounds	2005
A truvada hypersensitivity reaction simulating abacavir hypersensitivity. AIDS (London, England), 2007, Oct-18, Volume: 21, Issue:16 Topics: Adolescent; Anti-Retroviral Agents; Deoxycytidine; Drug Combinations; Drug Hypersensitivity; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; HIV Infections; HIV-1; Humans; Male; Organophosphorus Compounds	2007
Cross-allergy between 5-iodo-2'-deoxycytidine and idoxuridine. Journal of the American Academy of Dermatology, 1987, Volume: 17, Issue:1 Topics: Adult; Antiviral Agents; Bromodeoxycytidine; Cross Reactions; Deoxycytidine; Drug Eruptions; Drug Hypersensitivity; Female; Humans; Idoxuridine; Male; Patch Tests	1987